Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics

British Journal of Cancer

Volumn 88, Issue 8, 2003, Pages 1239-1247

  Broutet, N ^a   Plebani, M ^b   Sakarovitch, C ^a   Sipponen, P ^c   Megraud F ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c JORVI HOSPITAL   (Finland)

Author keywords

Atrophic gastritis; Biomarkers; Diagnosis; Helicobacter pylori; Pepsinogen

Indexed keywords

GASTRIN; PEPSINOGEN; PEPSINOGEN II; TUMOR MARKER;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ATROPHIC GASTRITIS; CANCER SCREENING; DYSPEPSIA; EUROPE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRECANCER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; RECEIVER OPERATING CHARACTERISTIC; STOMACH MUCOSA;

EID: 0038823754     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600877     Document Type: Article

References (39)

1. Altman DG (1991a) Comparing groups - continuous data. In Practical Statistics for Medical Research, pp 179-228. London: Chapman & Hall/CRC
2. Altman DG (1991b) Relation between two continuous variables. In Practical Statistics for Medical Research, pp 277-324. London: Chapman & Hall/CRC
3. Altman DG (1991c) ROC curve. In Practical Statistics for Medical Research, pp 417-478. London: Chapman & Hall/CRC
4. Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyasaki T, Miki K, Graham DY (1992) Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 102: 760-766
5. Borch K, Axelsson CK, Halgreen H, Damkjaer Nielsen M, Ledin T, Szesci PB (1989) The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. Scand J Gastroenterol 24: 870-876
6. Correa P (1989) Chronic gastritis. In Gastrointestinal and Oesophageal Pathology, Whitehead R (ed) pp 402-420. London: Churchill Livingstone
7. Correa P, Fox J, Fontham E, Ruiz B, Lin Y, Zavala D, Taylor N, Mackinley D, De Lima E, Portilla H, Zarama G (1990a) Helicobacter pylori and gastric carcinoma. Cancer 66: 2569-2574
8. Correa P, Haenszel W, Cuello C (1975) A model for gastric cancer epidemiology. Lancet 2: 58-60
9. Correa P, Haenszel W, Cuello C, Zavala D, Fontham E, Zarama G, Tannenbaum S, Collazos T, Ruiz B (1990b) Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res 50: 4737-4740
10. Covi L, Lipman R, McNair DM, Crezlinsky T (1979) Symptomatic volunteers in multicenter drug trials. Progr Neuro-Psychopharmacol 3: 521
11. Craanen ME, Blok P, Dekker W, Ferwerda J, Tytgat GNJ (1991) Prevalence of subtypes of intestinal metaplasia in gastric antral mucosa. Dig Dis Sci 36: 1529-1536
12. Dixon MF, Genta R, Yardley JH, Correa P (1996) Classification and grading of gastritis: the updated Sydney System. Am J Surg Pathol 20: 1161-1181
13. El-Omar E, Oien K, Murray LS, El-Nujumi A, Wirz A, Gillen D, Williams C, Fullarton G, McColl KEL (2000) Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori. Gastroenterology 118: 22-30
14. Eurohepygast Study Group (2002) Risk factors for atrophic chronic gastritis in a European population - results of the Eurohepygast study. Gut 50: 779-785
15. Figura N, Cetta F, Angelico M, Montalto G, Cetta D, Pacenti L, Vindigni C, Vaira D, Festuccia F, De Santis A, Rattan G, Giannace R, Campagna S, Gennari C (1998) Most Helicobacter pylori-infected patients have specific antibodies, and some also have H. pylori antigens and genomic material in the bile: is it a risk factor for gallstone formation? Dig Dis Sci 43: 854-862
16. Granberg C, Mansikka A, Lehtonen OP, Kujari H, Grönfors R, Nurmi H, Räihä I, Stalhberg MR, Leino R (1993) Diagnosis of Helicobacter pylori infection by using pyloriset EIA-G and EIA-A for detection of serum immunoglobulin G (IgG) and IgA antibodies. J Clin Microbiol 31: 1450-1453
17. Heikkinen M, Janatuinen E, Mayo K, Mégraud F, Julkunen R, Pikkarainen P (1997) Usefulness of anti-Helicobacter pylori and anti-CagA antibodies in the selection of patients for gastroscopy. Am J Gastroenterol 92: 2225-2229
18. Hosmer DW, Lemeshow S (2000) Area under ROC curve. In Applied Logistic Regression, Sons JW (ed) pp 220-230. New York: Wiley-Interscience
19. Ihamáki T, Kekki M, Sipponen P, Siurala M (1985) The sequelae and course of chronic gastritis during a 30- to 34-year bioptic follow-up study. Scand J Gastroenterol 20: 485-491
20. Ihamäki T, Saukkonen M, Siurala M (1978) Long-term observation of subjects with normal mucosa and with superficial gastritis: results of 23-27 years' follow-up examinations. Scand J Gastroenterol 13: 771-775
21. Kekki M, Samloff IM, Varis K, Ihamäki T (1991) Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Scand J Gastroenterol 26: 109-116
22. Kekki M, Siurala M, Varis K, Sipponen P, Sistonen P, Nevanlinna HR (1987) Classification principles and genetics of chronic gastritis. Scand J Gastroenterol 22: 1-28
23. Knight T, Wyatt J, Wilson A, Greaves S, Newell D, Hengels K, Corlett M, Webb P, Forman D, Elder J (1996) Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high-risk groups. Br J Cancer 73: 819-824
24. Kuipers EJ, Perez-Perez GI, Meuwissen SGM, Blaser MJ (1995) Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 87: 1777-1780
25. Ley C, Mohar A, Guarner J, HerreraGoepfert R, Figueroa LS, Halperin D, Parsonnet J (2001) Screening markers for chronic atrophic gastritis in Chiapas, Mexico. Cancer Epidemiol Biomarkers Prev 10: 107-112
26. Mégraud F, Lehn N, Lind T, Bayerdorffer E, O'Morain C, Spiller R, Unge P, Van Zanten SV, Wrangstadh M, Burman CF (1999) Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother 43: 2747-2752
27. Miki K, Ichinose M, Kakei N, Yahagi N, Matsushima M, Tsukada S, Ishihama S, Shimizu Y, Susuki T, Kurokawa K, Takahashi K (1995) The clinical application of the serum pepsinogen I and II levels as a mass screening method for gastric cancer. In Aspartic Proteinases: Structure, Function, Biology, and Biomedical Implications, Takahashi K (ed) pp 139-143. New York: Plenum Press
28. Miki K, Ichinose M, Shimizu A, Huang SC, Oka H, Furihata C, Matsushima T, Takahashi K (1987) Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jap 22: 133-141
29. Oksanen A, Sipponen P, Miettinen A, Sarna S, Rautelin H (2000) Evaluation of blood tests to predict normal gastric mucosa. Scand J Gastroenterol 35: 791-795
30. Palli D, Decarli A, Cipriani F, Forman D, Amadori D, Avellini C, Giacosa A, Manca P, Russo A, Salkeld RM, Samloff IM, Fraumeni JFJ, Blot WJ, Buiatti E (1991) Plasma pepsinogens, nutrients, and diet in areas of Italy at varying gastric cancer risk. Cancer Epidemiol Biomarkers Prev 1: 45-50
31. Plebani M (1993) Pepsinogens in health and disease. Crit Rev Clin Lab Sci 30: 273-328
32. Plebani M, Basso D, Cassaro M, Brigato, Luca, Scrigner M, Toma A, Di Mario F, Rugge M (1996) Helicobacter pylori serology in patients with chronic gastritis. Am J Gastroenterol 91: 954-958
33. Price AB (1991) The Sydney System: histological division. J Gastroenterol Hepatol 6: 209-222
34. Samloff IM, Varis K, Ihamaki T, Siurala M, Trotter JI (1982) Relationships among serum pepsinogen I, serum pepsinogen II, and serum gastric mucosal histology. Gastroenterology 83: 204-209
35. Sipponen P, Kekki M, Siurala M (1991) The Sydney system: epidemiology and natural history of chronic gastritis. J Gastroenterol Hepatol 6: 244-251
36. Tytgat G (1991) The Sydney System: endoscopic division. Endoscopic appearances in gastritis/duodenitis. J Gastroenterol Hepatol 6: 223-234
37. Webb MP, Hengels KJ, Moller H, Newell DG, Palli D, Elder JB, Coleman MP, De Backer G, Forman D (1994) The epidemiology of low serum pepsinogen A levels and an international association with gastric cancer rates. Gastroenterology 107: 1335-1344
38. Webb PM, Crabtree JE, Forman D (1999) Gastric cancer, cytotoxin-associated gene A-positive Helicobacter pylori, and serum pepsinogens: an international study. Gastroenterology 116: 269-276
39. Yamaoka Y, Kodama T, Graham DY, Kashima K (1998) Comparison of four serological tests to determine the CagA or VacA status of Helicobacter pylori strains. J Clin Microbiol 36: 3433-3434